Clinical Trial Update: Optimum Induction Therapy of Low-risk APL [NA]

View source ↗

Summary

A clinical trial (NCT05832320) at Peking University People's Hospital is evaluating optimum oral induction therapy for low-risk acute promyelocytic leukemia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Promyelocytic Leukemia, Induction Therapy | NA | Status: RECRUITING